Reference number : GC-2017-Q3-01017, amendment number : , agreement type : G, recipient legal name : Tung, Matthew (Xenon Pharmaceuticals Inc.), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Experience Awards, program name french : Bourses Expérience, program purpose english : nan, program purpose french : nan, agreement title english : Implementing a Proteomic Approach to Studying Irreversible Time Dependent Inhibition of CYP Enzymes, agreement title french : Implementing a Proteomic Approach to Studying Irreversible Time Dependent Inhibition of CYP Enzymes, agreement number : USRAI, agreement value : 4500.0, agreement start date : 2017-10-18, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada